nach oben

Erschienen in:

21.03.2019 | Original Article

Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region

verfasst von: Mengya Chen, Meng Wu, Xingxing Hu, Jiajia Yang, Renfang Han, Yubo Ma, Xu Zhang, Yaping Yuan, Rui Liu, Guangming Jiang, Shengqian Xu, Jianhua Xu, Zongwen Shuai, Faming Pan

Erschienen in: Clinical Rheumatology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the role of methylation levels of the IFN regulatory factor 8 (IRF8) gene promoter in the development of ankylosing spondylitis (AS).

Methods

In this study, we compared the methylation levels of the IRF8 gene promoter between 99 AS patients and 99 healthy controls using MethylTarget approach. Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) was performed to compare the mRNA levels of the IRF8 gene in the other 19 AS patients and 19 healthy controls.

Results

Differential methylation was found in 91 CpG sites of the IRF8 gene promoter, and 4 CpG regions were highly methylated in AS patients compared to healthy controls (p < 0.05). In the verification stage, we found that the mRNA levels of the IRF8 gene in AS patients were significantly lower than that in controls (AS 0.77 (0.39–1.74), P = 0.038). Positive correlations between methylation of the IRF8 gene and the duration of disease, BASFI, and ESR were observed in AS patients.

Conclusions

We found a significant hypermethylation of the IRF8 gene promoter and a downregulation of the mRNA levels of the IRF8 gene in AS patients. This suggests that aberrant methylation of the IRF8 gene promoter may probably contribute to the development and pathogenesis of AS through regulating the expression of mRNA.

Nur mit Berechtigung zugänglich

Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390. https://doi.org/10.1016/S0140-6736(07)60635-7 CrossRef

Bakland G, Nossent HC, Gran JT (2005) Incidence and prevalence of ankylosing spondylitis in northern Norway. Arthritis Care Res 53(6):850–855. https://doi.org/10.1002/art.21577 CrossRef

Xiang Y-J, Dai S-M (2008) Prevalence of rheumatic diseases and disability in China. Rheumatol Int 29(5):481–490. https://doi.org/10.1007/s00296-008-0809-z CrossRefPubMed

Mowla K, Rajaei E, Jalali MT, Zayeri ZD (2018) Threatening biomarkers in lupus pregnancy: biochemistry and genetic challenges. Front Biol 13(1):28–35. https://doi.org/10.1007/s11515-017-1477-8 CrossRef

Mowla K, Saki MA, Jalali MT, Zayeri ZD (2017) How to manage rheumatoid arthritis according to classic biomarkers and polymorphisms? Front Biol 12(3):183–191. https://doi.org/10.1007/s11515-017-1452-4 CrossRef

Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40(10):1823–1828. https://doi.org/10.1002/1529-0131(199710)40:10<1823::AID-ART15>3.0.CO;2-1 CrossRefPubMed

Hanson A, Brown MA (2017) Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin N Am 43(3):401–414. https://doi.org/10.1016/j.rdc.2017.04.006 CrossRef

Ge R, Pan F, Liao F, Xia G, Mei Y, Shen B, Zhang T, Gao J, Zhang L, Duan Z, Xu S, Xu J (2011) Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only study. Mol Biol Rep 38(4):2281–2284. https://doi.org/10.1007/s11033-010-0359-9 CrossRefPubMed

Ding N, Hu Y, Zeng Z, Liu S, Liu L, Yang T, Wu S, Fan D, Xu S, Xu J, Wang J, Pan F (2015) Case-only designs for exploring the interaction between FCRL4 gene and suspected environmental factors in patients with ankylosing spondylitis. Inflammation 38(2):632–636. https://doi.org/10.1007/s10753-014-9970-6 CrossRefPubMed

10.

Jia Y, Han S, Li J, Wang H, Liu J, Li N, Yang X, Shi J, Han J, Li Y, Bai X, Su L, Hu D (2017) IRF8 is the target of SIRT1 for the inflammation response in macrophages. Innate Immun 23(2):188–195. https://doi.org/10.1177/1753425916683751 CrossRefPubMed

11.

Feng XG, Xu XJ, Ye S, Lin YY, Chen P, Zhang XJ, Lin GY, Lin XQ (2011) Recent chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort. Scand J Rheumatol 40(4):289–291. https://doi.org/10.3109/03009742.2011.560891 CrossRefPubMed

12.

Zhao M, Wang Z, Yung S, Lu Q (2015) Epigenetic dynamics in immunity and autoimmunity. Int J Biochem Cell Biol 67:65–74. https://doi.org/10.1016/j.biocel.2015.05.022 CrossRefPubMed

13.

Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science (New York, NY) 293(5532):1068–1070. https://doi.org/10.1126/science.1063852 CrossRef

14.

Chavez-Valencia RA, Chiaroni-Clarke RC, Martino DJ, Munro JE, Allen RC, Akikusa JD, Ponsonby AL, Craig JM, Saffery R, Ellis JA (2018) The DNA methylation landscape of CD4(+) T cells in oligoarticular juvenile idiopathic arthritis. J Autoimmun 86:29–38. https://doi.org/10.1016/j.jaut.2017.09.010 CrossRefPubMed

15.

Ding W, Pu W, Wang L, Jiang S, Zhou X, Tu W, Yu L, Zhang J, Guo S, Liu Q, Ma Y, Chen S, Wu W, Reveille J, Zou H, Jin L, Wang J (2018) Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4(+) and CD8(+) T cells. J Invest Dermatol 138(5):1069–1077. https://doi.org/10.1016/j.jid.2017.12.003 CrossRefPubMed

16.

Hong KM, Kim HK, Park SY, Poojan S, Kim MK, Sung J, Tsao BP, Grossman JM, Rullo OJ, Woo JM, McCurdy DK, Rider LG, Miller FW, Song YW (2017) CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3zeta-chain expression in T cells. Rheumatology (Oxford, England) 56(3):467–476. https://doi.org/10.1093/rheumatology/kew405 CrossRef

17.

Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y, Wu H, Renauer P, Del Mar Ayala Gutierrez M, Castillo Palma MJ, Ortega Castro R, Fernandez-Roldan C, Raya E, Faria R, Carvalho C, Alarcon-Riquelme ME, Xiang Z, Chen J, Li F, Ling G, Zhao H, Liao X, Lin Y, Sawalha AH, Lu Q (2016) IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 75(11):1998–2006. https://doi.org/10.1136/annrheumdis-2015-208410 CrossRefPubMedPubMedCentral

18.

Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, Reinius L, Acevedo N, Taub M, Ronninger M, Shchetynsky K, Scheynius A, Kere J, Alfredsson L, Klareskog L, Ekstrom TJ, Feinberg AP (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 31(2):142–147. https://doi.org/10.1038/nbt.2487 CrossRefPubMedPubMedCentral

19.

Nile CJ, Read RC, Akil M, Duff GW, Wilson AG (2008) Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 58(9):2686–2693. https://doi.org/10.1002/art.23758 CrossRefPubMed

20.

Long H, Yin H, Wang L, Gershwin ME, Lu Q (2016) The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun 74:118–138. https://doi.org/10.1016/j.jaut.2016.06.020 CrossRefPubMed

21.

Hao J, Liu Y, Xu J, Wang W, Wen Y, He A, Fan Q, Guo X, Zhang F (2017) Genome-wide DNA methylation profile analysis identifies differentially methylated loci associated with ankylosis spondylitis. Arthritis Res Ther 19(1):177. https://doi.org/10.1186/s13075-017-1382-1 CrossRefPubMedPubMedCentral

22.

Lu R (2008) Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol 29(10):487–492. https://doi.org/10.1016/j.it.2008.07.006 CrossRefPubMedPubMedCentral

23.

Lee W, Kim HS, Baek SY, Lee GR (2016) Transcription factor IRF8 controls Th1-like regulatory T-cell function. Cell Mol Immunol 13(6):785–794. https://doi.org/10.1038/cmi.2015.72 CrossRefPubMed

24.

Ouyang X, Zhang R, Yang J, Li Q, Qin L, Zhu C, Liu J, Ning H, Shin MS, Gupta M, Qi CF, He JC, Lira SA, Morse HC 3rd, Ozato K, Mayer L, Xiong H (2011) Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun 2:314. https://doi.org/10.1038/ncomms1311 CrossRefPubMedPubMedCentral

25.

Meyer MA, Baer JM, Knolhoff BL, Nywening TM, Panni RZ, Su X, Weilbaecher KN, Hawkins WG, Ma C, Fields RC, Linehan DC, Challen GA, Faccio R, Aft RL, DeNardo DG (2018) Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Nat Commun 9(1):1250. https://doi.org/10.1038/s41467-018-03600-6 CrossRefPubMedPubMedCentral

26.

Saito E, Suzuki D, Kurotaki D, Mochizuki A, Manome Y, Suzawa T, Toyoshima Y, Ichikawa T, Funatsu T, Inoue T, Takami M, Tamura T, Inagaki K, Kamijo R (2017) Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro. Cytotechnology 69(3):443–450. https://doi.org/10.1007/s10616-016-0013-z CrossRefPubMed

27.

Echigo T, Hasegawa M, Shimada Y, Inaoki M, Takehara K, Sato S (2006) Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases. Arch Dermatol Res 298(1):38–45. https://doi.org/10.1007/s00403-006-0661-5 CrossRefPubMed

28.

Pernis AB (2009) Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 265(6):644–652. https://doi.org/10.1111/j.1365-2796.2009.02099.x CrossRefPubMed

29.

Rajaei E, Haybar H, Mowla K, Zayeri ZD (2018) Metformin one in a million efficient medicines for rheumatoid arthritis complications: inflammation, osteoblastogenesis, cardiovascular disease, malignancies. Curr Rheumatol Rev 14. https://doi.org/10.2174/1573397114666180717145745

30.

Steinman RM (2003) The control of immunity and tolerance by dendritic cell. Pathologie-biologie 51(2):59–60CrossRefPubMed

31.

Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvanen AC, Ronnblom L, Behrens TW, Graham RR, Vyse TJ (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7(10):e1002341. https://doi.org/10.1371/journal.pgen.1002341 CrossRefPubMedPubMedCentral

32.

Chrabot BS, Kariuki SN, Zervou MI, Feng X, Arrington J, Jolly M, Boumpas DT, Reder AT, Goulielmos GN, Niewold TB (2013) Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun 14(8):471–478. https://doi.org/10.1038/gene.2013.42 CrossRefPubMedPubMedCentral

33.

Lin JD, Wang YH, Liu CH, Lin YC, Lin JA, Lin YF, Tang KT, Cheng CW (2015) Association of IRF8 gene polymorphisms with autoimmune thyroid disease. Eur J Clin Investig 45(7):711–719. https://doi.org/10.1111/eci.12463 CrossRef

34.

Jiang Y, Wang H, Yu H, Li L, Xu D, Hou S, Kijlstra A, Yang P (2016) Two genetic variations in the IRF8 region are associated with Behcet’s disease in Han Chinese. Sci Rep 6:19651. https://doi.org/10.1038/srep19651 CrossRefPubMedPubMedCentral

35.

Qiu Y, Zhu Y, Yu H, Yi S, Su W, Cao Q, Yuan G, Kijlstra A, Yang P (2017) Ocular Behcet’s disease is associated with aberrant methylation of interferon regulatory factor 8 (IRF8) in monocyte-derived dendritic cells. Oncotarget 8(31):51277–51287. https://doi.org/10.18632/oncotarget.17235 CrossRefPubMedPubMedCentral

36.

Qiu Y, Yu H, Zhu Y, Ye Z, Deng J, Su W, Cao Q, Yuan G, Kijlstra A, Yang P (2017) Hypermethylation of interferon regulatory factor 8 (IRF8) confers risk to Vogt-Koyanagi-Harada disease. Sci Rep 7(1):1007. https://doi.org/10.1038/s41598-017-01249-7 CrossRefPubMedPubMedCentral

37.

Costantino F, Talpin A, Said-Nahal R, Leboime A, Zinovieva E, Zelenika D, Gut I, Charon C, Izac B, Weissman M, Chiocchia G, Reveille J, Breban M, Garchon HJ (2017) A family-based genome-wide association study reveals an association of spondyloarthritis with MAPK14. Ann Rheum Dis 76(1):310–314. https://doi.org/10.1136/annrheumdis-2016-209449 CrossRefPubMed

38.

de Andres MC, Perez-Pampin E, Calaza M, Santaclara FJ, Ortea I, Gomez-Reino JJ, Gonzalez A (2015) Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res Ther 17:233. https://doi.org/10.1186/s13075-015-0748-5 CrossRefPubMedPubMedCentral

39.

Lai NS, Chou JL, Chen GC, Liu SQ, Lu MC, Chan MW (2014) Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis. Mol Biol Rep 41(6):3773–3780. https://doi.org/10.1007/s11033-014-3242-2 CrossRefPubMed

40.

Karami J, Mahmoudi M, Amirzargar A, Gharshasbi M, Jamshidi A, Aslani S, Nicknam MH (2017) Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun 18(3):170–175. https://doi.org/10.1038/gene.2017.17 CrossRefPubMed

41.

Aslani S, Mahmoudi M, Garshasbi M, Jamshidi AR, Karami J, Nicknam MH (2016) Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol 35(11):2723–2731. https://doi.org/10.1007/s10067-016-3403-x CrossRefPubMed

42.

Masumi A, Tamaoki S, Wang IM, Ozato K, Komuro K (2002) IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett 531(2):348–353CrossRefPubMed

43.

Bigley V, Maisuria S, Cytlak U, Jardine L, Care MA, Green K, Gunawan M, Milne P, Dickinson R, Wiscombe S, Parry D, Doffinger R, Laurence A, Fonseca C, Stoevesandt O, Gennery A, Cant A, Tooze R, Simpson AJ, Hambleton S, Savic S, Doody G, Collin M (2018) Biallelic interferon regulatory factor 8 mutation: a complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. J Allergy Clin Immunol 141(6):2234–2248. https://doi.org/10.1016/j.jaci.2017.08.044 CrossRefPubMedPubMedCentral

44.

Tamura T, Ozato K (2002) ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interf Cytokine Res 22(1):145–152. https://doi.org/10.1089/107999002753452755 CrossRef

45.

Guo S, Zhu Q, Jiang T, Wang R, Shen Y, Zhu X, Wang Y, Bai F, Ding Q, Zhou X, Chen G, He DY (2017) Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis. Mod Rheumatol 27(3):441–447. https://doi.org/10.1080/14397595.2016.1218595 CrossRefPubMed

46.

Liu JF, Li YS, Drew PA, Zhang C (2016) The effect of celecoxib on DNA methylation of CDH13, TFPI2, and FSTL1 in squamous cell carcinoma of the esophagus in vivo. Anti-Cancer Drugs 27(9):848–853. https://doi.org/10.1097/cad.0000000000000396 CrossRefPubMed

47.

Mok A, Rhead B, Holingue C, Shao X, Quach HL, Quach D, Sinclair E, Graf J, Imboden J, Link T, Harrison R, Chernitskiy V, Barcellos LF, Criswell LA (2018) Hypomethylation of CYP2E1 and DUSP22 promoters associated with disease activity and erosive disease among rheumatoid arthritis patients. Arthritis Rheum 70(4):528–536. https://doi.org/10.1002/art.40408 CrossRef

Titel: Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region
verfasst von: Mengya Chen
Meng Wu
Xingxing Hu
Jiajia Yang
Renfang Han
Yubo Ma
Xu Zhang
Yaping Yuan
Rui Liu
Guangming Jiang
Shengqian Xu
Jianhua Xu
Zongwen Shuai
Faming Pan
Publikationsdatum: 21.03.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 8/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-019-04505-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

26.04.2024 | Hüft-TEP | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region

Abstract

Objectives

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

Correction to: Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes

Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare

Correction to: Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients

Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study

Extractable synovial fluid in inflammatory and non-inflammatory arthritis of the knee

Systematic reviews and meta-analysis in rheumatology: a gentle introduction for clinicians

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin